Search research articles
Contact Us
Filters
Showing results (241-250 of 248) with videos related to
Page
of 25
Sort By:
You have reached the last page of results.
This site can display upto 248 results.
Cancer Research and Treatment
|
August 20, 2024
Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience
Jiwon Koh, Jinyong Kim, Go-Un Woo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 5, 2019
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors
Bhumsuk Keam, Chang Kyung Kang, Kang Il Jun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 14, 2024
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study
Ryan Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Breast Cancer (Tokyo, Japan)
|
June 24, 2026
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial
Takashi Yamanaka, Joohyuk Sohn, Kazuki Sudo, et al.
NPJ Breast Cancer
|
August 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai, et al.
BMC Cancer
|
August 10, 2025
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
Jieun Lee, Hee Kyung Ahn, Kyung-Hun Lee, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 2, 2022
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
Stephen L Chan, Martin Schuler, Yoon-Koo Kang, et al.
Genome Medicine
|
July 20, 2023
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
Yeon Hee Park, Seock-Ah Im, Kyunghee Park, et al.
Page
of 25
Search research articles
Search
Showing results (241-250 of 248) with videos related to
Sort By:
Page
of 25
You have reached the last page of results.
This site can display upto 248 results.
Cancer Research and Treatment
|
August 20, 2024
Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year Experience
Jiwon Koh, Jinyong Kim, Go-Un Woo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 5, 2019
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors
Bhumsuk Keam, Chang Kyung Kang, Kang Il Jun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 14, 2024
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study
Ryan Ying Cong Tan, Whee Sze Ong, Kyung-Hun Lee, et al.
Breast Cancer (Tokyo, Japan)
|
June 24, 2026
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trial
Takashi Yamanaka, Joohyuk Sohn, Kazuki Sudo, et al.
NPJ Breast Cancer
|
August 22, 2024
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
Emi Noguchi, Takashi Yamanaka, Hirofumi Mukai, et al.
BMC Cancer
|
August 10, 2025
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
Jieun Lee, Hee Kyung Ahn, Kyung-Hun Lee, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 2, 2022
A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors
Stephen L Chan, Martin Schuler, Yoon-Koo Kang, et al.
Genome Medicine
|
July 20, 2023
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer
Yeon Hee Park, Seock-Ah Im, Kyunghee Park, et al.
Page
of 25